Johnson & Johnson Names Larry Merlo Chair Designate Of Planned New Consumer Health Company

Healthcare major Johnson & Johnson (JNJ) announced Wednesday the appointment of Larry Merlo as Non-executive Chair Designate for its planned new consumer health company's Board of Directors.

Johnson & Johnson in November 2021 announced the planned separation to create new Johnson & Johnson and the New Consumer Health company.

In May, the company had announced the appointment of Thibaut Mongon as Chief Executive Officer Designate of the new company.

The company said additional directors will be determined and announced in the coming months as the planned separation process progresses. The separation is expected to occur in 2023 subject to legal requirements including consultation with works councils and employee representatives.

Merlo will formally assume the role as Non-executive Chair upon completion of the planned separation.

Merlo, with over 30 years of experience, previously served as President and CEO of CVS Health from 2011 to 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Juul Labs, an e-cigarette maker, said it has reached settlements with more than 5,000 vaping lawsuits in the United States. The cases were related to personal injury, consumer class action, government entity, and Native American tribes. In a statement, the company said it cannot disclose the settlement amount at this time as part of the settlement and court process. Apple Inc. plans to start using American-made processors from the new advanced chip factory in Phoenix, Arizona operated by chip giant Taiwan Semiconductor Manufacturing Co., according to its Chief Executive Officer Tim Cook. At an event in the factory in Arizona, which was attended by U.S. President Joe Biden, it was also announced that TSMC will invest $40 billion in the new factory. Lidl US has recalled its 8.4 oz Favorina branded Advent Calendar, i.e., Premium Chocolate with a Creamy Filling, citing potential Salmonella contamination, the U.S. Food and Drug Administration said. The products were available for sale at Lidl stores between October 12, 2022 and December 5, 2022. They will have a BEST IF USED BY year of 2023, and barcode number of 4056489516965.
Follow RTT